Table 2.
Univariate analysis of laboratory findings of patients with variceal and nonvariceal UGIB n (%)
| Laboratory findings |
Causes of UGIB |
P | |
| Variceal (n = 47) | Nonvariceal (n = 214) | ||
| Hemoglobin, (g/dL) | 8.6 ± 2.2 | 8.5 ± 2.6 | 0.731 |
| Hematocrit, (%) | 25.8 ± 6.3 | 25.9 ± 7.3 | 0.965 |
| WBC (× 103/ mm3) | 12.2 ± 8.7 | 14.3 ± 13.5 | 0.319 |
| Platelets (× 103/mm3) | 165.0 ± 115.8 | 248.6 ± 129.9 | < 0.001 |
| < 100 × 103/mm3 | 16 (34) | 23 (11) | < 0.001 |
| BUN (mg/dL) | 31 ± 18 | 44 ± 29 | 0.003 |
| Creatinine (mg/dL) | 1.3 ± 0.7 | 1.6 ± 1.8 | 0.190 |
| Albumin (g/L) | 2.8 ± 0.7 | 3.2 ± 0.7 | 0.001 |
| Globulin (g/L) | 3.7 ± 0.9 | 3.2 ± 0.8 | < 0.001 |
| Albumin/globulin ratio < 1 | 38 (81) | 83 (45) | < 0.001 |
| Total bilirubin (mg/dL) | 4.1 ± 5.8 | 2.3 ± 5.5 | 0.054 |
| SGOT (U/L) | 133 ± 187 | 62 ± 107 | 0.001 |
| > 2 × UNL | 25 (53) | 36 (20) | < 0.001 |
| SGPT (U/L) | 62 ± 76 | 36 ± 50 | 0.003 |
| > 2 × UNL | 8 (21) | 21 (12) | 0.359 |
| SGOT/SGPT > 1 | 43 (92) | 132 (75) | 0.025 |
| Alkaline phosphatase (U/L) | 158 ± 112 | 115 ± 105 | 0.015 |
| Prothrombin time (s) | 21 ± 11 | 16 ± 8 | 0.002 |
| > 12.5 s | 44 (94) | 58 (29) | < 0.001 |
UNL: Upper normal limit.